2016

Glatirameracetate

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2017

Darbepoetin alfa

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2016

Enoxaparin

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2017

Infliximab

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2017

Adalimumab

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2018

PEG-IFN-beta 1a

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2019

PEG-Darbepoetin

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2019

Anti-IL17

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2020

Anti-IL6R

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2020

Anti-IL17/anti-TNFa bispecific

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2020

Anti-HER2/HER3 bispecific

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2020

Anti c-Met

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2019

Anti -PD1

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2020

Anti EGFR/HER3 bispecific

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2019

Senexin

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2018

NS5B inhibitor

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2019

NS5A inhibitor

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration
2019

NS3 inhibitor

  • Development
  • Preclinical Studies
  • I Phase
  • II Phase
  • III Phase
  • Registration